Literature DB >> 8813088

Influence of alpha-thalassemia trait on spleen function in sickle cell anemia patients with high HbF.

A D Adekile1, M Tuli, M Z Haider, K Al-Zaabi, S Mohannadi, A Owunwanne.   

Abstract

Spleen function was studied in a group of 20 Kuwaiti SS patients (aged 2-12 years), using 99mTc-labeled tin colloid scintigraphy. They were screened for the alpha-thalassemia determinants which are prevalent in the Arabian Peninsula [-alpha (3.7 kb) deletion, alpha2-globin gene polyadenylation signal (AATAAA => AATAAG) mutation, and 5' IVS-I splice junction pentanucleotide (GAGGTGAGG => GAGG) deletion] with a combination of polymerase chain reaction and allele-specific oligonucleotide (ASO) hybridization techniques. The patients were divided into three groups depending on the result of their colloid uptake. Group I consisted of 7 patients (35.0%) with normally visualized spleens, Group II consisted of 5 (25.0%) with partial visualization, and in Group III there were 8 (40.0%) in whom the spleen was not visualized at all. The significant distinguishing features among those in Groups I and III were mean corpuscular volumes (MCVs) of 74.1 +/- 5.1 and 90.1 +/- 6.6 fl (P<0.0001) and mean corpuscular hemoglobins (MCHs) of 22.4 +/- 2.7 and 27.5 +/- 4.0 pg (P<0.05), respectively. The overall frequency of alpha-thalassemia determinants in the study was 35.0%; however, the frequencies in Groups I, II, and III were 57.1, 30.0, and 18.8%, respectively. alpha-Thalassemia trait, therefore, appears to be associated with normal splenic function in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813088     DOI: 10.1002/(SICI)1096-8652(199609)53:1<1::AID-AJH1>3.0.CO;2-V

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Alpha thalassemia among sickle cell anaemia patients in Kampala, Uganda.

Authors:  Irene Lubega; Christopher M Ndugwa; Edison A Mworozi; James K Tumwine
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

2.  Insights into determinants of spleen injury in sickle cell anemia.

Authors:  Sara El Hoss; Sylvie Cochet; Mickaël Marin; Claudine Lapouméroulie; Michael Dussiot; Naïm Bouazza; Caroline Elie; Mariane de Montalembert; Cécile Arnaud; Corinne Guitton; Béatrice Pellegrino; Marie Hélène Odièvre; Frédérique Moati; Caroline Le Van Kim; Yves Colin Aronovicz; Wassim El Nemer; Valentine Brousse
Journal:  Blood Adv       Date:  2019-08-13

3.  Influence of alpha thalassemia on clinical and laboratory parameters among nigerian children with sickle cell anemia.

Authors:  Oladele S Olatunya; Dulcineia M Albuquerque; Adekunle Adekile; Fernando F Costa
Journal:  J Clin Lab Anal       Date:  2018-08-20       Impact factor: 2.352

Review 4.  The prevalence of sickling abnormality in Oman: A review of relevant publications

Authors:  Nawal Al-Mashaikhi; Abdulhakim Al-Rawas; Yasser Wali; Ashraf Soliman; Doaa Khater
Journal:  Acta Biomed       Date:  2022-08-31

Review 5.  The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.

Authors:  Adekunle Adekile
Journal:  Med Princ Pract       Date:  2020-09-04       Impact factor: 1.927

6.  Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing.

Authors:  Adekunle Adekile; Nagihan Akbulut-Jeradi; Rasha Al Khaldi; Maria Jinky Fernandez; Jalaja Sukumaran
Journal:  J Pers Med       Date:  2021-05-23

7.  Comment on "Molecular analysis and association with clinical and laboratory manifestations in children with sickle cell anemia".

Authors:  Marilda Souza Goncalves
Journal:  Rev Bras Hematol Hemoter       Date:  2014-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.